Financial information


18 results

Financial information

Ipsen delivers strong H1 2021 results and upgrades full-year...

We are pleased to announce our strong H1 2021 financial results with Group sales of…

Financial information

Ipsen delivers encouraging sales growth in Q1, confirms full...

We are pleased to announce encouraging sales growth of 5.5% at CER (0.6% as reported)…

Financial information

FY2020 financial results

In the face of the profound challenges and disruptions linked to the COVID-19 pandemic in…

Financial information

Ipsen – Full Year 2020 Results – Conference Call – Feb...

Ipsen is pleased to host a conference call to discuss the Group’s Year 2020 results…

Financial information

Ipsen announces 3.1% Group Sales Growth, reinstates 2020 gui...

We are pleased to announce a resilient financial performance for H1 2020, despite the…

Financial information

Ipsen – Half Year 2020 Sales Conference Call – Thursda...

David Loew, Chief Executive Officer, is pleased to host a conference call to discuss the…

Financial information

FY2019 and beyond: paving the way for our next phase of grow...

Today, Ipsen announced its FY2019 results, and I would like to take a moment to…

Financial information

Ipsen – Full Year 2019 Results Conference Call – Febru...

Date:            Thursday, February 13, 2020 Time:            Conference call and webcast – 2:30pm CET / 8:30 EST…

Financial information

Ipsen – 2019 Q3 results – October 24, 2019 at 2:30pm CEST

To register to the webcast, please click here. Ipsen will hold a conference call Thursday,…

Financial information

Ipsen will hold a conference call Thursday, 25 July 2018 at ...

Participants should dial in to the call approximately five to ten minutes prior to its…

Event

Ipsen – Investor Day 2019

To register for the webcast, please Click here.

Financial information
  • 1
  • 2
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021